Thursday May 23rd (provisionnal)
What is wrong with EVAR?
Rapid introduction of unproven technology: EVAS – a case study
Who picks up the pieces when the balloon of “promising technology” bursts?
The ice is thinner than the skaters think! Reminding physicians of their duties when introducing new technology
How would a perfect device overcome the problems?
How should we introduce the next Wondergraft?
NICE Guidelines – how are they generated? Why do they matter within and outside UK?
Can you accept EVAR Trials 10-year results and still justify EVAR for all-comers?
It is all about (the health) economics. Is it really?
Square pegs in round holes: Aneurysm screening and ruptured aneurysms in the ‘NASTY’ era.
Square pegs in round holes: Patient choice and high risk patients in the ‘NASTY’ era.
The evidence NICE ignored: review of RCT evidence is not enough and why?
Same evidence base, different guidelines; What is correct ?
Personalised decision making for AAA
Arch branch TEVAR has come of age: series of 70
Cerebral protection during total arch fenestrated TEVAR
When should you consider OR with FET?
Endovascuar treatment of Type A dissection: lessons from TAVI
What is the state of the art for Type A dissection?
LSA – When and why should we bother?
World experience of the snorkel/chimney technique: report from the PERICLES registry
How to get the best use of EndoAnchors: critical analysis of >500 implants.
Jean Paul de Vries
Large snake on the block: latest on Anaconda FEVAR
Developments in Zenith platform for FEVAR
Pursuing the perfect seal zone: Balance between operative safety and long-term efficacy
Target vessel stents – how to match stent for the purpose
Increased complexity of FEVAR equals increased complications